rs36006195
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2
The NM_000184.3(HBG2):c.4G>T(p.Gly2Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000739 in 676,238 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as other (no stars).
Frequency
Genomes: 𝑓 0.000014 ( 0 hom., cov: 23)
Exomes 𝑓: 0.0000056 ( 0 hom. )
Consequence
HBG2
NM_000184.3 missense
NM_000184.3 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 2.21
Publications
10 publications found
Genes affected
HBG2 (HGNC:4832): (hemoglobin subunit gamma 2) The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'- epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]
HBG2 Gene-Disease associations (from GenCC):
- hemoglobinopathy Toms RiverInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-beta-thalassemia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary persistence of fetal hemoglobin-sickle cell disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- cyanosis, transient neonatalInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
PM1
In a modified_residue N-acetylglycine; in form Hb F1 (size 0) in uniprot entity HBG2_HUMAN
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HBG2 | ENST00000336906.6 | c.4G>T | p.Gly2Cys | missense_variant | Exon 1 of 3 | 1 | NM_000184.3 | ENSP00000338082.4 | ||
| ENSG00000284931 | ENST00000642908.1 | c.4G>T | p.Gly2Cys | missense_variant | Exon 1 of 3 | ENSP00000495346.1 | ||||
| ENSG00000239920 | ENST00000380259.7 | n.*1307G>T | non_coding_transcript_exon_variant | Exon 7 of 8 | 5 | ENSP00000369609.3 | ||||
| ENSG00000239920 | ENST00000380259.7 | n.*1307G>T | 3_prime_UTR_variant | Exon 7 of 8 | 5 | ENSP00000369609.3 |
Frequencies
GnomAD3 genomes AF: 0.0000138 AC: 2AN: 144944Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
144944
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000388 AC: 3AN: 77352 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
77352
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000565 AC: 3AN: 531294Hom.: 0 Cov.: 6 AF XY: 0.00 AC XY: 0AN XY: 280872 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
3
AN:
531294
Hom.:
Cov.:
6
AF XY:
AC XY:
0
AN XY:
280872
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
14554
American (AMR)
AF:
AC:
0
AN:
25016
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
15490
East Asian (EAS)
AF:
AC:
3
AN:
31828
South Asian (SAS)
AF:
AC:
0
AN:
50774
European-Finnish (FIN)
AF:
AC:
0
AN:
32584
Middle Eastern (MID)
AF:
AC:
0
AN:
2186
European-Non Finnish (NFE)
AF:
AC:
0
AN:
329960
Other (OTH)
AF:
AC:
0
AN:
28902
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00000000298604), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.342
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000138 AC: 2AN: 144944Hom.: 0 Cov.: 23 AF XY: 0.0000143 AC XY: 1AN XY: 70048 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
2
AN:
144944
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
70048
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
39110
American (AMR)
AF:
AC:
0
AN:
14366
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3412
East Asian (EAS)
AF:
AC:
2
AN:
5120
South Asian (SAS)
AF:
AC:
0
AN:
4288
European-Finnish (FIN)
AF:
AC:
0
AN:
9352
Middle Eastern (MID)
AF:
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
AC:
0
AN:
66178
Other (OTH)
AF:
AC:
0
AN:
1928
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.250
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: other
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
HEMOGLOBIN F (MALAYSIA) Other:1
Aug 05, 2011
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;.
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;N;.
PhyloP100
PROVEAN
Benign
.;.;N;.
REVEL
Uncertain
Sift
Uncertain
.;.;D;.
Sift4G
Uncertain
.;.;D;.
Polyphen
0.53
.;.;P;.
Vest4
0.21, 0.30
MutPred
Gain of catalytic residue at G2 (P = 0.0292);Gain of catalytic residue at G2 (P = 0.0292);Gain of catalytic residue at G2 (P = 0.0292);Gain of catalytic residue at G2 (P = 0.0292);
MVP
0.98
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -13
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.